One of the premier pharmaceutical manufacturers, Roche India has launched a new vaccine for the raging coronavirus pandemic.
As per the analysis conducted by Roche, the vaccine, named as ‘cocktail’, the Indian Medical Research Council (IMRC), has approved the use of this new vaccine on an emergency basis. In a notification regarding this released by Cipla, it is mentioned:
“This vaccine will bring the best results for those coronavirus infected patients affected at medium or mild degree.
Further, the number of patients for admission to the hospitals have reduced considerably and also the extent of percentage death due to coronavirus is brought down by 70% with the administration of this new vaccine.
A packet of the vaccine containing 2 doses can be used for 2 patients.
The price of a single dose is Rs. 59750/-! A packet containing 2 doses of this vaccine is priced at Rs. 119500/-!”